M B Youdim

The Goldfish as a Drug Discovery Vehicle for Parkinson's Disease and Other Neurodegenerative Disorders

H. Pollard, M. Youdim, H B Pollard, 1993, Annals of the New York Academy of Sciences.

The Anti‐Parkinson Drug Rasagiline and Its Cholinesterase Inhibitor Derivatives Exert Neuroprotection Unrelated to MAO Inhibition in Cell Culture and in Vivo

W Tatton, W. Tatton, M. Youdim, 2001, Annals of the New York Academy of Sciences.

Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases.

M. Youdim, M B Youdim, S. Shoham, 2000, Cellular and molecular biology.

Mechanism of 6-hydroxydopamine neurotoxicity.

M. Youdim, Y. Glinka, M B Youdim, 1997, Journal of neural transmission. Supplementum.

Brain iron: a lesson from animal models.

M. Youdim, S. Yehuda, M B Youdim, 1989, The American journal of clinical nutrition.

Iron in the Parkinsonian substantia nigra.

P Riederer, K. Jellinger, E. Hirsch, 1997, Movement disorders : official journal of the Movement Disorder Society.

Green tea polyphenol (–)‐epigallocatechin‐3‐gallate prevents N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurodegeneration

S. Mandel, M. Youdim, O. Weinreb, 2001, Journal of neurochemistry.

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

P Riederer, K. Jellinger, P. Riederer, 1991, Journal of neurochemistry.

The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system.

M. Youdim, S. Yehuda, M B Youdim, 2000, Cellular and molecular biology.